Clinical And Genetic Aspects Of Sudden Cardiac Death In The Practice Of Sports Medicine
Download Clinical And Genetic Aspects Of Sudden Cardiac Death In The Practice Of Sports Medicine full books in PDF, epub, and Kindle. Read online free Clinical And Genetic Aspects Of Sudden Cardiac Death In The Practice Of Sports Medicine ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Lynne Millar |
Publisher |
: Morgan & Claypool Publishers |
Total Pages |
: 164 |
Release |
: 2012 |
ISBN-10 |
: 9781615043866 |
ISBN-13 |
: 1615043861 |
Rating |
: 4/5 (66 Downloads) |
Synopsis Clinical and Genetic Aspects of Sudden Cardiac Death in the Practice of Sports Medicine by : Lynne Millar
Sudden cardiac death is the leading cause of non-traumatic mortality in young (
Author |
: Dhavendra Kumar |
Publisher |
: Springer |
Total Pages |
: 921 |
Release |
: 2018-01-17 |
ISBN-10 |
: 9783319661148 |
ISBN-13 |
: 3319661140 |
Rating |
: 4/5 (48 Downloads) |
Synopsis Cardiovascular Genetics and Genomics by : Dhavendra Kumar
This title reflects the exponential growth in the knowledge and information on this subject and defines the extensive clinical translation of cardiovascular genetics and genomics in clinical practice. This concise, clinically oriented text is targeted at a broad range of clinicians who manage patients and families with a wide range of heterogeneous inherited cardiovascular conditions. Cardiovascular Genetics and Genomics: Principles and Clinical Practice includes a concise and clear account on selected topics written by a team of leading experts on clinical cardiovascular genetics. Each chapter include key information to assist the clinician and case histories have been incorporated to reflect contemporary practice in clinical cardiovascular genetics and genomics. Therefore this will be of key importance to all professionals working in the discipline, from clinicians and trainees in cardiology, cardiac surgery, electrophysiology, immunology through geneticists, nursing staff and those involved in precision medicine.
Author |
: Johnathan Cooper-Knock |
Publisher |
: Biota Publishing |
Total Pages |
: 62 |
Release |
: 2013-09-01 |
ISBN-10 |
: 9781615044290 |
ISBN-13 |
: 1615044299 |
Rating |
: 4/5 (90 Downloads) |
Synopsis Clinical and Molecular Aspects of Motor Neuron Disease by : Johnathan Cooper-Knock
In this e-book, motor neuron disease (MND) shall refer to amyotrophic lateral sclerosis (ALS), the most common neurodegenerative disorder affecting both the upper and lower motor neurons. With the discovery of C9ORF72 expansions in approximately 10% of all MND cases, in certain populations, we stand at the brink of a new era of MND research and hopefully treatment facilitated by the ability to associate a relatively large group of patients with a similar disease mechanism. This review will summarise both current clinical management of MND and our present understanding of the molecular pathogenesis of MND. Study of C9ORF72-MND has the potential to rapidly advance both of these aspects in the coming years.
Author |
: Meena Upadhyaya |
Publisher |
: Biota Publishing |
Total Pages |
: 81 |
Release |
: 2014-02-01 |
ISBN-10 |
: 9781615046454 |
ISBN-13 |
: 1615046453 |
Rating |
: 4/5 (54 Downloads) |
Synopsis The Molecular Biology of Neurofibromatosis Type 1 by : Meena Upadhyaya
Neurofibromatosis type 1 (NF1) is a common autosomal dominantly inherited, tumour predisposition syndrome affecting 1/3,000-4,000 individuals worldwide. This inherited disorder results from the mutational inactivation of the NF1 gene on human chromosome 17. The NF1 gene contains 61 exons that give rise to 12kb mRNA encoding neurofibromin. The 327kDa (2,818 amino acid) neurofibromin protein is expressed in most tissues and has a number of alternative isoforms. Neurofibromin is a tumour suppressor protein and down-regulates cellular Ras. Increased active Ras-GTP levels also stimulate the important PI3K/AKT/mTOR signalling pathway that protects cells from apoptosis. The major clinical featues of NF1 include multiple café-au-lait macules, skinfold freckles, iris Lisch nodules, and neurofibromas. The diagnostic criteria for clinical diagnosis have been well established. However, there are a small number of cases in which the diagnosis is not certain. The germline mutation rate for the NF1 gene is 10-fold higher than that observed for most other inherited diseases. Using a combination of different techniques, almost 95% of germline mutations can be detected. To date, only two firm genotype phenotype correlations have been reported. NF1 phenotype exhibits large variations within a family, evidence for modifying loci regulating the expression of an NF1 gene is beginning to emerge. We also are gaining knowledge on the molecular mechanisms associated with the development of different types of tumours. It is encouraging that the results of recent laboratory and clinical research are finally being translated into clinical trials. With the availability of high-throughput technologies, sophisticated animal models, and multi-centre clinical trials, the future for NF1 sufferers is looking optimistic. This book aims to provide an overview of the genetic and clinical aspects of NF1 and its role in both NF1-associated and sporadic tumour development. It emphasizes the recent developments in this field and some of the promising on-going clinical trials.
Author |
: Ramon Brugada |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 340 |
Release |
: 2010-01-18 |
ISBN-10 |
: 9781848829275 |
ISBN-13 |
: 1848829272 |
Rating |
: 4/5 (75 Downloads) |
Synopsis Clinical Approach to Sudden Cardiac Death Syndromes by : Ramon Brugada
Clinical cardiologists are encountering an important challenge in the caring of families with inherited cardiac diseases. The majority of the inherited cardiac diseases causing sudden death express themselves at variable ages in the form of altered muscle function (i.e hypertrophic or dilated cardiomyopathy) or in the form of arrhythmias (i.e. Brugada syndrome, long QT syndrome). However, it is not uncommon that the first sign of the disease may actually be sudden cardiac death, even before the identification of clear clinical abnormalities. In this last decade, with more than 50 new disease-associated genes identified, the possibility of genetic testing has opened a new opportunity to disease diagnosis and prevention. Clinical and genetic research is continuously on-going not only to identify those at risk, but to better define their level or risk still with limited success.
Author |
: Robert W. Battle |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: 201 |
Release |
: 2015-10-26 |
ISBN-10 |
: 9780323391207 |
ISBN-13 |
: 0323391206 |
Rating |
: 4/5 (07 Downloads) |
Synopsis Sports Cardiology, An Issue of Clinics in Sports Medicine by : Robert W. Battle
A sports cardiologist evaluates affected athletes and suggests the most appropriate treatment options that may allow them to stay active in sports. This issue will discuss the following topics: Cardiovascular Adaptation and Remodeling to Rigorous Athletic Training, The Historical Perspective of Athletic Sudden Death, The ECG in Elite Athletes, The Management of Athletes with Congenital Heart Disease, Genetic testing in athletesThe Impact of Sports Cardiology on the Practice of Sports Medicine and many more!
Author |
: Giuseppe Limongelli |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: |
Release |
: 2018-04-02 |
ISBN-10 |
: 9780323610476 |
ISBN-13 |
: 0323610471 |
Rating |
: 4/5 (76 Downloads) |
Synopsis Clinical and Molecular Aspects of Cardiomyopathies: On the road from gene to therapy, An Issue of Heart Failure Clinics, E-Book by : Giuseppe Limongelli
This issue of Heart Failure Clinics--edited by Drs. Giuseppe Limongelli, Sharlene Day, and Perry Elliott--will cover Clinical and Molecular Aspects of Cardiomyopathies: On the Road from Gene to Therapy. Topics include, but are not limited to, Epidemiology and Clinical aspects of Genetic Cardiomyopathies, Existing and New therapies, Gene editing and gene-based therapeutics, Controversies surrounding exercise in genetic cardiomyopathies, Genetic infiltrative cardiomyopathies, LV Noncompaction, Clinical presentation and natural history of hypertrophic cardiomyopathy in Rasopathies, and Moelcular basis and new treatments of cardiac diseases in Rasopathies.
Author |
: Dhavendra Kumar |
Publisher |
: Oxford Monographs on Medical G |
Total Pages |
: 853 |
Release |
: 2014-10-15 |
ISBN-10 |
: 9780199896028 |
ISBN-13 |
: 019989602X |
Rating |
: 4/5 (28 Downloads) |
Synopsis Genomic Medicine by : Dhavendra Kumar
Preceded by Genomics and clinical medicine / edited by Dhavendra Kumar. [First edition]. 2008.
Author |
: |
Publisher |
: |
Total Pages |
: 1228 |
Release |
: 1987 |
ISBN-10 |
: UIUC:30112065974955 |
ISBN-13 |
: |
Rating |
: 4/5 (55 Downloads) |
Synopsis Cumulated Index Medicus by :
Author |
: Matteo Vatta |
Publisher |
: Frontiers Media SA |
Total Pages |
: 130 |
Release |
: 2017-09-12 |
ISBN-10 |
: 9782889452811 |
ISBN-13 |
: 2889452816 |
Rating |
: 4/5 (11 Downloads) |
Synopsis Current Challenges in Cardiovascular Molecular Diagnostics by : Matteo Vatta
The field of cardiovascular genetics has tremendously benefited from the recent application of massive parallel sequencing technology also referred to as next generation sequencing (NGS). However, along with the discovery of additional genes associated with human cardiac diseases, the analysis of large dataset of genetic information uncovered a much more complex and variegated landscape, which often departs from the comfort zone of the monogenic Mendelian diseases image that clinical molecular geneticists have been well acquainted with for many decades. It is now clear that, in addition to highly penetrant genetic variants, which in isolation are able to recapitulate the full clinical presentation when expressed in animal models, we are now aware that a small but significant fraction of subjects presenting with cardiac muscle diseases such as cardiomyopathies or primary arrhythmias such as long QT syndrome (LQTS), may harbor at least two deleterious variants in the same gene (compound heterozygous) or in different gene (double heterozygous). Although the clinical presentation in subjects with more than one deleterious variant appears to be more severe and with an earlier disease onset, it somehow changes the viewpoint of clinical molecular geneticists whose aim is to identify all possible genetic contributors to a human condition. In this light, the employment in clinical diagnostics of the NGS technology, allowing the simultaneous interrogation of a DNA target spanning from large panel of genes up to the entire genome, will definitely aid at uncovering all such contributors, which will have to be tested functionally to confirm their role in human cardiac conditions. The uncovering of all clinically relevant deleterious changes associated with a cardiovascular disease would probably increase our understanding of the clinical variability commonly occurring among affected family relatives, and potentially provide with unexpected therapeutic targets for the treatment of symptoms related to the presence of “accessory” deleterious genetic variants other than the key molecular culprit. The objective of this Research Topic is to explore the current challenges presenting to the cardiovascular genetics providers, such as clinical geneticists, genetic counselors, clinical molecular geneticists and molecular pathologists involved in the diagnosis, counseling, testing and interpretation of genetic tests results for the comprehensive management of patients affected by cardiovascular genetic disorders.